Crescent Capital Consulting’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $4.24M | Buy |
71,672
+7,627
| +12% | +$451K | 0.7% | 34 |
|
|
2021
Q3 | $2.76M | Buy |
64,045
+3
| +0% | +$129 | 0.51% | 48 |
|
|
2021
Q2 | $2.51M | Sell |
64,042
-718
| -1% | -$28.1K | 0.47% | 52 |
|
|
2021
Q1 | $2.35M | Buy |
64,760
+24,737
| +62% | +$896K | 0.51% | 52 |
|
|
2020
Q4 | $1.48M | Buy |
+40,023
| New | +$1.48M | 0.38% | 62 |
|